BeOne Medicines Ltd. — Director's Dealing 2019

Nov 22, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2019-11-20

Reporting Person: Glazer Donald W. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-20	Ordinary Shares	G	81060	—	Disposed	3630366	Direct

Footnotes

F1: Bona fide gifts of shares which are exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-5.